Posted by: admin on: February 29, 2012
Azilsartan is a new drug successfully tried on adults and now being studied on pediatric group. Here is what the study on adults has to say. Team@CMHF
Posted by: admin on: December 6, 2011
The new calcium channel blocker azelnidipine found to have an added effect on Olmesartan action on hypertensive diabetic patients, has an advantage in chronic kidney patients. Here is the study. Team@CMHF